Fibronectin type Ⅲ domain-containing 5 in cardiovascular and metabolic diseases:a promising biomarker and therapeutic target

作者：Xin Zhang; Can Hu; Hai-ming Wu; Zhen-guo Ma; Qi-zhu Tang

来源：Acta Pharmacologica Sinica, 2021, (9): 1390-1400.

• cardiovascular and metabolic diseases
• FNDC5
• biomarker
• therapeutic target

Cardiovascular and metabolic diseases are the leading causes of death and disability worldwide and impose a tremendous socioeconomic burden on individuals as well as the healthcare system.Fibronectin